Mercer Global Advisors Inc Gilead Sciences, Inc. Transaction History

Mercer Global Advisors Inc

$35.2 Billion
Q1 2024

A detailed history of Mercer Global Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 355,771 shares of GILD stock, worth $24.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

355,771

Previous 324,286 9.71%

Holding current value

$24.4 Million

Previous $26.3 Million 0.79%

% of portfolio

0.07%

Previous 0.08%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $2.25 Million - $2.75 Million	31,485 Added 9.71%	355,771 $26.1 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $919,831 - $1.04 Million	12,554 Added 4.03%	324,286 $26.3 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $3.25 Million - $3.55 Million	44,015 Added 16.44%	311,732 $23.4 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2.37 Million - $2.71 Million	31,208 Added 13.2%	267,717 $20.6 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $2.85 Million - $3.24 Million	36,818 Added 18.44%	236,509 $19.6 Million

Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $6.56 Million - $9.41 Million	105,214 Added 111.36%	199,691 $17.1 Million
Q3 2022 Nov 15, 2022	BUY	$59.54 - $68.01 $763,779 - $872,432	12,828 Added 15.71%	94,477 $5.83 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $78,383 - $88,283	-1,358 Reduced 1.64%	81,649 $5.05 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $610,650 - $765,210	10,543 Added 14.55%	83,007 $4.94 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $468,174 - $531,386	7,216 Added 11.06%	72,464 $5.26 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $234,951 - $253,487	3,471 Added 5.62%	65,248 $4.56 Million
Q2 2021 Aug 10, 2021	BUY	$63.47 - $69.35 $100,599 - $109,919	1,585 Added 2.63%	61,777 $4.25 Million
Q1 2021 Aug 10, 2021	BUY	$60.0 - $68.46 $186,960 - $213,321	3,116 Added 5.46%	60,192 $3.89 Million
Q1 2021 May 11, 2021	BUY	$60.0 - $68.46 $957,240 - $1.09 Million	15,954 Added 38.8%	57,076 $3.69 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $579,812 - $660,669	-10,235 Reduced 19.93%	41,122 $2.4 Million
Q3 2020 Dec 10, 2020	BUY	$62.1 - $78.08 $26,703 - $33,574	430 Added 0.84%	51,357 $3.25 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $352,006 - $408,744	-4,866 Reduced 8.72%	50,927 $3.92 Million
Q1 2020 May 18, 2020	SELL	$62.63 - $80.22 $2.24 Million - $2.87 Million	-35,738 Reduced 39.04%	55,793 $4.17 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $299,288 - $329,207	4,857 Added 5.6%	91,531 $5.95 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.72 Million - $3.01 Million	43,564 Added 101.05%	86,674 $5.49 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $7,300 - $8,186	118 Added 0.27%	43,110 $2.91 Million
Q1 2019 Apr 23, 2019	BUY	$62.53 - $70.05 $383,871 - $430,036	6,139 Added 16.66%	42,992 $2.8 Million
Q1 2019 Apr 12, 2019	BUY	$62.53 - $70.05 $2.3 Million - $2.58 Million	36,853 New	36,853 $2.31 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Gilead Sciences, Inc. Transaction History